share_log

Piper Sandler Initiates Coverage On Gritstone Bio With Overweight Rating, Announces Price Target of $6

Piper Sandler Initiates Coverage On Gritstone Bio With Overweight Rating, Announces Price Target of $6

派珀·桑德勒以增持评级启动对Gritstone Bio的报道,宣布目标股价为6美元
Benzinga Real-time News ·  2022/10/31 05:04

Piper Sandler analyst Edward Tenthoff initiates coverage on Gritstone Bio (NASDAQ:GRTS) with a Overweight rating and announces Price Target of $6.

派珀·桑德勒分析师爱德华·滕索夫以增持评级启动了对Gritstone Bio(纳斯达克股票代码:GRTS)的报道,并宣布目标股价为6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发